| Section | Details |
|---|---|
| Product Name | CIT/MIT Tank Preservative (3:1 Blend) |
| IUPAC Name | 5-chloro-2-methyl-4-isothiazolin-3-one (CIT) and 2-methyl-4-isothiazolin-3-one (MIT) blend |
| Chemical Formula | CIT: C4H4ClNOS MIT: C4H5NOS |
| Synonyms & Trade Names |
CIT: CMIT, MCI, 5-chloro-2-methyl-4-isothiazolin-3-one MIT: MI, 2-methyl-4-isothiazolin-3-one Common blend trade names: Kathon, Kathon CG, Biocide CIT/MIT (3:1) Industry references often use "CIT/MIT" or “MCI/MI” for clarity. |
| HS Code & Customs Classification |
HS Code: 3808.94 Customs classification under “Disinfectants; prepared bactericides...” Grade and packing form (liquid concentrate or premix) influence declaration category in some regions. Dilution, stabilizer content, and function (industrial or consumer) also drive exact coding during export. |
Experienced manufacturers track both process-derived variables and downstream application impacts for all CIT/MIT variants. Blending CIT and MIT requires precise ratio control due to differences in active content, physical stability, and response to formulation pH, presence of amines, or residual process salts.
Raw material selection typically results in impurity and trace byproduct differences. Grade, function (tank preservation versus in-can preservation or wet-state application), and regional regulatory compliance specify the acceptable range for byproducts like chlorinated isothiazolones or residual intermediates. Producer in-process controls target batch-to-batch consistency, adjusting feed concentrations and solvent ratios to maintain specified blend balance and avoid off-target degradation.
Core purification at manufacturer level includes multi-stage distillation or solvent extraction, suited to the grade and customer specification. Residual water, trace salts, or organic byproducts are subject to release limits determined by end-use tolerance and toxicity profile. Each lot's physical properties (odor, color, pH, assay of actives) and biological performance undergo testing aligned with customer and regulatory requirements.
Downstream, the CIT/MIT blend’s physical behavior—stability in dilution, interaction with tank materials, and reactivity with other formulation ingredients—depends on the process history and grade-specific stabilizer use. Non-standard grades present risks during blending or storage, contributing to batch stratification or precipitate formation in bulk tanks.
Final release criteria at manufacturer level reflect technical agreements and quality parameters expected for intended industrial use, with routine validation against actual in-use tank system profiles. Pack sizes, preservative systems, and delivery forms are defined to reduce contamination risks and preserve blend efficacy until use.
CIT/MIT tank preservative, a blend of 5-chloro-2-methyl-4-isothiazolin-3-one (CIT) and 2-methyl-4-isothiazolin-3-one (MIT), is typically supplied as an aqueous solution. Most grades present as a clear to slightly yellow liquid. Odor can be sharp or faintly pungent, linked to isothiazolinone content and grade purity. Melting point and boiling point data lose significance for aqueous formulations. The solution’s flash point depends on water concentration and exact formulation; pure actives possess markedly different flash points and must be referenced to neat material, not product blend. Density ranges shift with concentration and presence of secondary stabilizers. The blend dissolves readily in water, aiding tank-side application. Correct solution preparation ensures preservation effectiveness, and deviations in concentration or mixing protocol directly impact product performance and stability in storage.
Chemical stability depends on pH and temperature; breakdown risks grow in alkaline or hot environments, calling for regular tank monitoring. Reactivity limits handling options; mixing with strong nucleophiles, amines, or reducing agents can destabilize actives and form potentially hazardous byproducts.
Specifications for CIT/MIT blends are dictated by intended end-use, regional regulations, and downstream formulation requirements. Tables will differ across grades (industrial, cosmetic, or high-purity) and can include active content, allowable levels of impurities like sulfate, chloride, and unreacted starting materials, as well as pH and color index.
Impurity control is critical both for regulatory compliance and formulation compatibility. Most impurities relate to incomplete reaction, feedstock quality, or side reactions during synthesis. Limits reflect both what can be achieved through purification and what is required for safe use in permissible applications. Test methods often follow international standards, but in-house validated protocols ensure fit-for-purpose detection and quantification; method selection is tailored to sensitivity and robustness needs. The final release standard aligns with internal quality criteria and customer-specific tolerances.
Raw material selection centers on high-purity chloromethyl precursors and carefully controlled oxidants. Sourcing needs to guarantee consistent supply free from excessive heavy metals, organic contaminants, or unintended halogens that could migrate as impurities through the process.
The synthesis route leverages a controlled oxidation–chlorination pathway. Optimal yield demands tight regulation of temperature and pH during critical steps; exothermic reaction stages mandate robust cooling and mixing protocols. Reaction monitoring includes in-process analyses for precursor exhaustion and side-product formation.
Purification uses multistage extraction, phase-separation, activated carbon, or ion-exclusion steps, tailored according to impurity profile and grade required. Quality control throughout the batch cycle flags any off-spec excursions, with a final release mandated only after meeting critical-to-quality parameters verified by validated lab methods.
The CIT/MIT blend undergoes irreversible ring-opening in the presence of nucleophiles, strong base, or reducing agents, leading to loss of activity and formation of sulfur- and nitrogen-containing fragments. Reaction rates and predominant products depend on temperature, pH, and medium. This sensitivity provides both built-in environmental degradability and constraints for co-formulant compatibility in tank storage or process use.
Derivatives and downstream products are uncommon in commercial practice due to regulatory focus and environmental toxicology. Modification targets, where attempted, often aim at embedding the isothiazolinone core in less volatile or more controlled-release matrices, but any such process must address substantial regulatory and shelf stability hurdles.
Bulk storage requires moderate temperatures, with best practices favoring cool, dry, and dark environments to minimize hydrolysis and oxidation risks. Direct sunlight or UV exposure speeds up decomposition and should be avoided. Humidity is less problematic for aqueous solutions but can aggravate degradation in more concentrated or partly dried products.
Containers made from HDPE or other halogen-resistant plastics prove most compatible; metals risk catalyzing decomposition or corroding due to mild acidity. Shelf life varies by concentration and preservation system, with regular checks for color darkening, precipitate, or sulfurous odor shift as signals of instability. Final suitability must match customer requirements, especially where regulatory shelf-life mandates apply.
All manufacturing and tank handling call for sound understanding of toxicology. CIT/MIT solutions classify as skin and eye irritants; appropriate personal protective equipment—gloves, goggles, and aprons—remains standard in production and packaging. Vapors from concentrated forms or heated tanks pose respiratory hazards if not properly ventilated.
GHS classification varies with blend ratio and concentration, and local regulations may further define thresholds for hazard pictograms and precautionary statements. Toxicity data relates mainly to acute irritation potential; repeated or prolonged exposure increases risk for sensitization. Exposure limits do not universally apply; jurisdictions may set occupational exposure guidance. Safe transfer, spill response, and controlled neutralization practices develop in step with facility SOPs, batch scale, and tank volume.
Production capacity of CIT/MIT tank preservative directly tracks plant uptime, batch turnover, and supply-chain continuity for both raw materials and auxiliaries. CIT/MIT blends demand precise blending environments to maintain isothiazolinone ratios and low-level impurities, dictating batch size based on application category (water treatment, coatings, or I&I). For technical and industrial grades, capacity reservation fluctuates monthly depending on planned maintenance and downstream order cycles.
Availability varies between bulk and specialty lots. In peak demand periods, lead times expand from typical 2-4 week production cycles, with flexibility for run timing dictated by customer forecast reliability, raw material shipment safety margins, and order specificity.
Lead time ranges from 2-6 weeks, shifting shorter for recurring off-the-shelf specifications and longer for application-specific purity, dilution ratios, or certified packaging. MOQ depends on packaging and grade: standard industrial containers allow for lower MOQs compared to specialty grades specified for regulated industries. Strict release procedures for customized grades extend total cycle time, especially where additional batch validation or external compliance is triggered.
Standard packaging includes HDPE drums and intermediate bulk containers. For high-purity, biocidal or regulated-use blends, inert liner systems and tamper-evidence are specified to prevent cross-contamination and outgassing. Packaging dictates certain shelf stability and affects product protection for shipment over variable climates, particularly for export destinations subject to large temperature swings and humidity.
Bulk domestic shipments default to FOB or ex works. Exports to US, EU, and Asia-Pacific follow Incoterms reflecting container packing, port selection, and regional documentation. Payment terms support Letters of Credit and standard net 30 agreements with approved customers, while large-volume or specialized grades may require milestone-based payment aligned with production progress.
Raw material costs for CIT/MIT stem mainly from precursor chlorinated isothiazolinones, solvent bases, and stabilizer systems. Price movement ties directly to upstream chemical feedstock pricing, most notably for 5-chloro-2-methyl-4-isothiazolin-3-one and related aromatic intermediates. Energy price swings, especially for natural gas and coal in production regions, routinely disrupt both availability and spot pricing for feedstock chemicals. Environmental controls or shutdowns at supplier plants, especially in East Asia, cause further supply chain instability.
Product cost diverges by purity specification—industrial grade allows for wider ranges of by-products and stabilizer blend, while biocidal or cosmetic-use grades entail additional purification steps, tighter impurity profiles, and in many cases validation according to EU BPR or US EPA standards. Certified packaging, including food-grade liners or UN-standard drums, compounds costs further. The payment for third-party certification or extended compliance testing recurs for regulated-use variants and drives stepped price differences.
Global volume demand centers on Europe, US, China, and India, where water-based formulations maintain sustained growth. Seasonal volumes spike with industrial water treatment, legislative cycles for antimicrobial approvals, and swings in the polymer and coatings industry. Capacity expansions in mainland China and India moderate acute shortages but also expose global pricing to local regulatory and logistics disruptions.
North America and EU markets push for higher compliance and purity. US regulatory changes drive short-term surges in certificate-grade demand, while EU BPR re-registration cycles cause forward buying and last-minute regulatory stockpiling. China and India account for the majority of low-purity and base blend exports. Japan’s demand follows niche high-purity applications, often at a premium, with strong attention to downstream certification.
Prices through 2026 will likely hinge on feedstock market volatility, the pace of regulatory change, and capacity expansions in Asia. Regulatory tightening across the EU and North America should reinforce a higher price baseline for certified grades, while base industrial grades may see some softening if regional capacity exceeds demand cycles. Long-term supply contracts allow some insulation from spot volatility, but ongoing adjustments for compliance upgrades and formulation changes will persist.
This commentary draws from direct monitoring of market transaction data, production cost trending, customer order cycles, and public regulatory filings. Internal quality and capacity data inform production-side impacts, while market trends reflect both customer feedback and key sector indices.
Recent disruptions in chlorinated isothiazolinone availability, especially from East Asian producers, have resulted in tightening for high-purity and regulated-use grades. Customer qualification cycles extend as new feedstock sources require updated validation for compliance in biocidal and cosmetic applications.
Ongoing BPR (EU) and EPA (US) re-certifications for CIT/MIT have pushed suppliers and manufacturers to update supporting technical files, revisit labelling, and, in some cases, reformulate or validate new batch records. Import regulations in strategic key markets, especially for downstream blending customers, continue to evolve. As a result, documentation management absorbs increasing resources, and additional certificate testing of each batch is required for export.
Production teams have coordinated raw material procurement to diversify risk, seeking secondary suppliers for critical isothiazolinone intermediates and extending safety stock levels where feasible. Investment in in-line analytical controls for purity and impurity tracking strengthens batch-to-batch traceability, especially where compliance thresholds tighten without warning. Technical and quality functions continue to support customers with more frequent data submission and reformulation guidance to minimize disruption to downstream production and regulatory approval.
CIT/MIT tank preservatives intervene where microbial contamination in liquid formulations directly impacts product stability and operational efficiency. Production lines in paints and coatings, adhesives, latex emulsions, construction chemicals, and certain water-based process fluids rely on these preservatives to control bacterial and fungal growth. Facilities using open tank, recirculating, or continuous-feed systems often encounter system fouling, filter blockage, or loss of active ingredients due to biofilm accumulation when preservatives are absent or mismatched.
| Application | Recommended CIT/MIT Grade | Industrial Considerations |
|---|---|---|
| Paints & Coatings | Low-formaldehyde, low-impurity grade | Sensitive to trace formaldehyde, impurity carryover can affect gloss and shelf stability |
| Adhesives & Sealants | Medium-purity, standard water-soluble grade | Compatibility with thickening/viscosity agents, process water chemistry may change solubility profile |
| Latex Emulsions | High-purity, low odor grade | Odor control, risk of yellowing with high impurity loads, batch-to-batch consistency critical for emulsion particle stability |
| Construction Chemistries (e.g., admixtures) | Economical, general-purpose grade | Robustness needed against high mineral loads, focus on anti-microbial persistence over time instead of immediate activity |
| Process Water, Recirculating Cooling, Metalworking Fluids | Grade tailored to biocide-license conditions | Application-specific compliance with local biocide regulations, impact on foam formation, corrosion risk |
Selection of key parameters covers active ingredient ratio (CIT vs. MIT), impurity profile, formaldehyde donor content, solubility, and odor threshold. These values shift according to application: where paints and adhesives flag trace formaldehyde risk, process fluids watch foaming and compatibility with antifoam agents. Emulsions prioritize control of color shifts, while construction admixtures tighten focus on antimicrobial efficacy over formulation aesthetics.
Identify whether the preservative protects in-tank storage, protects during post-manufacture shelf life, or covers both. End-use application influences required purity, compatibility expectations, and final formulation approvals. Tanks with open-air exposure and variable load require a different approach than sealed transfer systems.
Review region-specific chemical registration, biocide-listing, and labeling demands before grade selection. Regulations in North America handle maximum active loads and allowable impurities differently than those in the EU or East Asia. Non-compliance at this step leads to downstream risk—batch rejection, labeling issues, or recall liability.
Purity targets depend on end-use. Paint producers often dictate low total halogen, low formaldehyde, and restricted odor grades, confirmed by release certification. Non-critical use in construction admixtures may accept higher impurity profile if bioactivity and cost remain in balance. Detailed impurity profiles are available on request and tied to each manufacturing route.
Formulators and production managers frequently select batch sizes between intermediate bulk to full container load, matching CIT/MIT grade not only to technical parameters but also to logistics, warehouse cycle, and price targets. High-purity grades command premium pricing, justified by reduced risk of rework, customer complaints, or regulatory incident.
Validation includes real-application screening: contamination challenge, shelf storage stability testing, and compatibility with production materials. Plant trials confirm impurity robustness, handling safety, and metering system compatibility. Manufacturers share release documentation, analytical certificates, and support specialist review until the customer signs off on the selected grade.
Our production sites involved in CIT/MIT tank preservative manufacturing operate under internationally recognized quality management systems. Production adheres to ISO-compliant routines, which guide all material movement from raw input to finished batch release. These controls address sourcing traceability, operator qualification, and documentation accuracy. Internal audits are performed regularly to benchmark plant compliance and to drive procedural updates based on new quality risk observations.
Third-party verification for CIT/MIT product lines covers compliance in line with biocidal product directives and relevant local chemical registration requirements. Certificate acquisition responds directly to downstream customer usage cases and end-market legislation. Any customer directed for particular regional certificates can coordinate directly with the quality or regulatory affairs team to ensure the supply matches expected compliance.
Each delivery batch is supported by COA documentation linked directly to the batch number and production log. Copies of internal in-process and release test records can be supplied as required to verify conformance to customer specifications. Long-term supporting documentation, such as traceability records and impurity profiles, is maintained per regulatory timelines and audit readiness protocols. Independent third-party laboratory reports may be provided for key impurity or stability endpoints upon coordinated request, subject to sample and test campaign timelines.
The CIT/MIT tank preservative line is supported by multi-line production facilities. This structure ensures priority allocation to key accounts and reduces exposure to single-site disruptions. Allocation logic follows customer agreement, historical draw-down rates, and forecasted demand windows. Requested volumes above a certain baseline will require lead time and procurement coordination, especially for customized packaging or formulation variants.
Main production runs operate on a continuous or semi-batch basis, depending on order volume and customer-specified grade. Production scheduling is managed based on both core tank inventory and confirmed contract volumes. Risk mitigation strategies for supply interruptions are embedded in logistics planning and raw material staging, especially when precursor chemicals are impacted by regional supply chain fluctuations.
Sample requests for standard CIT/MIT tank preservative grades are reviewed by the technical and sales application teams. Evaluation samples originate from commercial-scale batches, not from pilot or laboratory lots, to ensure accurate representation of commercial supply. Typical industry practice requires sample requesters to specify required test endpoints and intended use scenarios, which guides selection of appropriate grade and batch for delivery. Customized sample preparation can be arranged for application testing or non-standard formulation needs, with lead times agreed per inquiry.
Business cooperation models support frame agreements covering rolling forecasts, spot purchases, and scheduled call-offs under blanket contracts. Customers with variable draw schedules may coordinate deferred delivery or “hold stock” arrangements aligned with their storage and production rhythms. Partnership models are structured to support capacity reservation for core customers, as well as agile response to irregular demand surges. Detailed technical and logistics support during new project ramp-up or portfolio expansion is handled by a joint technical-commercial team, ensuring both rapid troubleshooting and proactive supply planning.
| Aspect | Industrial Commentary |
|---|---|
| Raw Material Selection | Raw materials for CIT/MIT manufacturing are selected based on supplier audit history, risk of variance in precursor purity, and the presence of trace contaminants. Vendor qualification requires multi-lot verification before onboarding. |
| Process Control | Process route is determined by downstream impurity tolerances and target product form. Key control points include intermediate monitoring to manage formaldehyde residual and byproduct formation. |
| Batch Consistency | Batch-to-batch consistency is evaluated through both in-process and endpoint analytics. Out-of-spec incidents are subject to root cause analysis with production, quality, and process engineering teams. |
| Release Criteria | Final batch release aligns with customer-defined acceptance criteria where contractual, or with internal factory release specifications. Review includes analytical, packaging integrity, and documentation check. |
Production environments for industrial preservatives, like CIT/MIT, push for raw materials with ensured traceability and reactivity control. Continuous evaluation of precursor purity affects downstream stability, especially when targeting ultra-low impurity grades for storage in bulk tanks. Many R&D groups focus on analytical method upgrades—HPLC and GC-MS techniques, for example—to map degradation profiles in complex water matrices. Across lab and pilot lines, micro-contaminant control during emulsion or slurry dispersion commands attention. Industrial feedback points to microbial strain adaptation, which drives investigation into blended isothiazolinone systems or synergy with non-volatile co-preservatives.
Demand traces most growth to end users in water-based process tanks: paint emulsion, adhesives, latex polymerization, and cooling water recirculation. Customers in geographies with shifting biocide registration regimes—especially those tightening labeling requirements on formaldehyde releasers—seek replacements that sustain shelf stability and tank uptime. R&D groups field requests for compatibility tests in high-pH and ionic strength compositions. These real-world field data feed back into candidate preservative blends, blending process routes, and on-site dosing system guidance.
One persistent challenge involves balancing fast microbial kill with long tank retention and minimizing end-product odor. Maintaining batch-to-batch reproducibility in active ingredient ratios calls for real-time in-process analytics, especially at kilo-scale reactor charge and during final filtration. Some producers tackle trace-chlorine and organic halide byproduct minimization at synthetic and formulation stages, adjusting temperature ramps or switching to closed-system material transfers. The adoption of dedicated stainless and lined reactors reduces cross-contamination with legacy microbials. Innovations in encapsulation and enhanced-release formulations emerge from multi-site collaboration, with technical trials showing measurable reduction in rapid degradation when these next-gen forms are applied to high-turnover tank systems.
Market demand patterns signal greater end-user technical audits, especially from multinationals responding to regional biocide directives. Supply-demand dynamics will follow the investment into plant reliability, data logging on preservative dosing systems, and the expansion into application support. Growth projections suggest highest uptake among mid-tier producers who require flexible preservative options due to shorter tank cleanout cycles and tighter stockholding protocols. Assessment of market risk increasingly incorporates scenario planning for raw input price volatility linked to methylisothiazolinone and chloroisothiazolinone supply chains.
Process lines shift towards semi-continuous and modular installations to maximize flexibility and minimize cleaning downtime between consecutive batches. A clear move appears towards integration of real-time microbial analytics and automated pre-filtration dosing. By optimizing synthesis conditions and venting, upstream sections minimize operator exposure risks and lower fugitive emissions. R&D cooperation with tank and process system OEMs leads to formulation guidance tuned for spray nozzles, static mixers, and variable dwell time environments—each scenario checked against tank corrosion/surface residue profiles.
Manufacturing R&D teams act to reduce total process waste, targeting both direct chemical footprints and energy use. Recovered solvents and water loops get recycled under robust QA protocols to cut down resource input per ton produced. Material specs shift towards enabling low-emission, low-residual application; field support includes life-cycle studies and material compatibility tests to anticipate compliance with upcoming eco-label regulations. Teams advance towards drop-in replacements for higher toxicity preservative classes in anticipation of tightening global ecolabel thresholds. Customer engagement now covers support for reformulation, alternate dosing, and residual monitoring to reduce overuse.
Application specialists draw on in-plant audits, customer tank system surveys, and sampling campaigns to identify microbe ingress points and address formulation bottlenecks on site. Technical engagement scopes out both upstream handling and downstream compatibility, cross-referencing batch records and field data with internal QA criteria. Specialist input on process water quality, agitation methods, and raw material upstream logistics gives customers actionable recommendations for storage and in-use dosing.
Support teams provide protocols for preservative dilution, blending, and tank dosing, referencing both historic and real-time process data. Typical support includes running side-by-side trial batches to confirm preservative consumption versus microbial load performance before full-scale adoption. Recommendations always consider pH, temperature, and residence time as tracked in customer installations, correlating dosing to tank geometry and material compatibility. Teams flag potential incompatibility issues with co-formulants and guide customers through mitigation measures before off-line contamination escalates.
Quality control specialists monitor customer feedback and process deviation reports, triggering root-cause investigations when performance falls short of technical expectations. Teams track batch traceability to shipment records, assure compliance with declared quality standards, and keep customers updated with technical bulletins based on new field findings or regulatory updates. Support continues throughout the customer tank life cycle, including periodic revalidations based on process changes and feedback-driven technical improvements.
As a factory producing CIT/MIT tank preservatives, every stage of our process takes place in-house. We handle synthesis, formulation, and packaging under one roof, using dedicated lines to avoid contamination and deliver steady product quality over each batch. Technicians monitor process parameters using calibrated equipment and cross-check every lot against agreed industry benchmarks.
High-volume water-based systems such as paints, adhesives, polymer latexes, concrete admixtures, and metalworking fluids commonly require broad-spectrum microbial control. Our CIT/MIT formulations offer the right blend to manage bacteria and fungi in these environments, reducing the risk of spoilage during both storage and end-use. Over the years, clients scaling operations from pilot to continuous production have relied on our technical batch data to replicate performance without unwanted downtime.
All raw materials come in under strict acceptance protocols. Each finished batch leaves with a certificate recording active content as verified by our on-site instruments. Internal teams track every deviation and document corrective actions, so buyers get documentation proven over extended shipment history. By controlling ingredient preparation, mixing, and final screening, we eliminate most variables that can affect tank preservative stability.
We fill CIT/MIT preservatives in closed drums, intermediate bulk containers, and totes, with tamper-evident closures and clear labeling. Automated filling stations minimize human contact, and every lot carries traceable batch codes. Volume commitments for regional and international clients run from single shipments to scheduled multi-load contracts. We maintain buffer stock for quick call-offs to cover short supply gaps on industrial lines.
Buyers often ask for guidance in matching the right preservative load for system pH, temperature profiles, and end-use requirements. Our technical team provides direct advice—either through joint sample evaluation or onsite assistance—to ensure correct dosing and seamless integration. When clients convert equipment or reformulate adjacent lines, we assist with compatibility checks and stability testing using real production materials, not just simulated lab blends.
Factories, distributors, and procurement teams are under constant pressure to manage costs while reducing risk. By controlling the process internally, we remove uncertainty from the sourcing equation. Long-term clients see fewer batch-to-batch discrepancies and minimal supply interruptions. Procurement schedules benefit from our advanced planning and direct communication, reducing the landing cost of each metric ton delivered to the plant gate. Our role as an integrated manufacturer means technical, logistical, and quality teams can respond without delay, supporting large-scale operations in real time.
At our production facility, CIT/MIT (a synergy of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one) stands among the most reliable tank preservatives for challenging water-based formulations. Through continuous batch monitoring and extensive collaboration with end users across multiple sectors, it’s clear CIT/MIT’s effectiveness depends on both technical dosing and practical demands—especially with microbial contamination levels fluctuating in real-world operations.
Our standard recommendation for CIT/MIT in fluid preservation lands at 25–60 ppm (active ingredient). Teams working with water-based adhesives, emulsions, or paints routinely confirm this as the sweet spot for controlling bacterial and fungal growth during storage. Industrial water systems, large-scale emulsion polymerization setups, and paint plants facing tough microbial loads may move toward the upper end. Routine factory audits emphasize: Under-dosing leads to sudden contamination spikes, over-dosing brings regulatory and handling challenges. Practical stability trials across adhesives and specialty coatings consistently demonstrate that levels below 25 ppm open the door to rapid spoilage—the product may begin to ferment and generate off-odors, resulting in a total loss of material and, more critically, productivity.
Quality assurance never takes shortcuts. Our R&D group runs preservative challenge tests at each dosage before a batch ships out. Actual preservation needs align with real process conditions—pH fluctuations, temperature swings, and contamination from recycled water streams all play a role. Within our own factory, adjustments are based on years of trending microbe counts and hands-on data, not theoretical models. Every dosing trial is logged to track chemical consumption and microbial counts over storage timelines. This direct evidence shapes our guidelines.
Our technical team maintains strict control over active ingredient percentages in each batch. Production records verify our CIT/MIT blends hit the required concentrations for optimal microbial defense. Tank-side application is as important as production: Our tech support group regularly visits customer plants to inspect dosers, verify calibration, and review preservation effectiveness in finished goods. We stock CIT/MIT in stable, easily dosed concentrations so facilities can maintain predictable preservation protocols, simplify handling, and avoid overuse—assuring both in-house safety and regulatory compliance.
Water-based formulations draw in contamination from many sources, especially during storage, transfer, or intermittent operation. Our audit teams often find microbial hotspots near seals, pump heads, or under-mixed tank bottoms. Recommendations always include routine cleaning schedules and regular microbe checks—CIT/MIT only works when paired with clean equipment and reliable monitoring. Facilities running single-shift or seasonal operations benefit from a slightly higher initial dose and periodic biocide “topping up” as an extra guard rail. Experience at our own plant shows how upholding strict hygiene, monitoring water quality, and sticking to a disciplined CIT/MIT dosing plan pays off with batch consistency and minimal downtime.
Global regulators, including the United States EPA, European BPR, and China’s Ministry of Ecology and Environment, maintain clear maximum use limits for CIT/MIT. We always supply current compliance information for each region. Our commitment: ship only legally compliant material and back customers with site-specific technical support if contamination challenges persist. Factories searching for robust, long-term microbial protection from a direct source can count on our consistent product quality, experienced application guidance, and ongoing support fielded by those who make the product, not simply sell it.
Dosing CIT/MIT at 25–60 ppm remains a proven, practical range that has kept our partners’ lines running clean year after year. We provide detailed batch histories, on-site trial support, and direct advice to help facility managers zero in on the best approach for every unique system.
At our production sites, manufacturing CIT/MIT tank preservative in volumes that support large-scale industrial use is a routine part of our operations. We know that consistent antimicrobial protection in water-based formulations—paints, adhesives, building materials—requires reliable access to high-grade preservatives in commercial quantities. Our customers in coatings, polymer emulsions, and similar sectors often need large packaging formats to minimize handling and streamline their processes.
We manufacture CIT/MIT under strict in-house controls and offer this blend in bulk packaging designed specifically for industrial procurement. Our most common formats for high-volume users include 200-liter drums and 1,000-liter intermediate bulk containers (IBCs). These options reduce the frequency of changeovers on dosing systems and cut down packaging waste at your plant. For continuous feed applications, these large units support uninterrupted operations. Smaller sizes are also available, but the bulk containers better match the scale and storage demands seen in manufacturing environments.
Consistency and stock security remain priorities for our industrial buyers. We plan our CIT/MIT production runs based on rolling forecasts and historical data, which lets us support repeat orders and spot-buys with short notice on standard bulk sizes. Our ongoing investment in tank storage, blending capacity, and on-site analytical labs at the production plant means we can adjust output in response to fluctuating demand from sectors like construction chemicals and pulp and paper.
For larger orders—multiple IBCs, full containers, or palletized lots—we coordinate closely with logistics partners to move product via road, rail, or seaborne container, following strict safety requirements for biocidal products. Most consignments leave our facility with full batch traceability, and we maintain safety data sheets and certificates of analysis ready for every lot.
Our standard lead time on bulk packaging is five to ten working days after receipt of purchase order and final technical agreement. Urgent orders are possible by drawing from buffer stock held near major industrial centers. Larger and repeat contracts allow for dedicated production slots and reserved logistics solutions, ensuring buyers who forecast needs have an extra measure of supply security. Seasonal peaks or force majeure events may affect lead times, but we address delays directly and communicate foreseeable risks as soon as they arise.
Our expertise as direct producers means every bulk lot comes from a controlled batch, with full analytical support and a clear sourcing record. Technical requests—adjustments to active ingredient ratios or tailored shelf-life studies—are handled by our in-house research and technical support teams. Sourcing directly from our plant, buyers eliminate unnecessary hand-offs, shorten delivery chains, and reduce the risk of product switching or contamination.
Secure supply of CIT/MIT in bulk supports many industries in maintaining product safety and operational efficiency. Our commitment as the manufacturer is to meet these industrial requirements with reliable production scheduling, robust packaging, and straightforward business support.
CIT/MIT preservatives, known in the industry for their efficacy as biocides, contain active substances that present clear transportation hazards. Over the years, our facility has shipped thousands of units across continents. The active blend of 5-chloro-2-methyl-4-isothiazolin-3-one and 2-methyl-4-isothiazolin-3-one demands respect for safety—this means compliance with strict laws under dangerous goods transport regulations both locally and abroad. We work with a full understanding of the hazard statements and keep up to date with changing regulations outlined by authorities like ADR for road, IMDG for sea, and IATA for air shipment. This is not academic policy; our logistics teams deal directly with these rules each time a shipment leaves our gates.
We classify our CIT/MIT Tank Preservative under the correct UN number, typically falling under UN 3082: Environmentally hazardous substance, liquid, n.o.s. (contains isothiazolinones). The classification as Class 9 requires correct hazard labeling—warning diamonds, environmental hazards, and proper marks. Trucks and shipping containers cannot move a liter without these. Customs authorities regularly inspect documentation and packaging for correct compliance. Any discrepancy creates real-world consequences such as costly delays, rejected shipments, and reputational risk. We regularly update our teams with the latest amendments to international regulations, reviewing SDS content and package labels at every batch release.
Any shipment from our factory includes a precise set of transport documents. A signed Dangerous Goods Declaration (DGD) or Multimodal Dangerous Goods Form travels with every consignment—our logistics division drafts and verifies each one. The Safety Data Sheet (SDS) aligned with GHS and local standards provides detailed composition and response instructions, several sections of which are referenced directly during border checks or at ports. The language on these documents always matches the receiving country's requirements. Batch traceability is tracked on documents and labels. This direct link between our production batch and the transport paperwork has solved thousands of regulatory queries over the years.
We fill CIT/MIT Tank Preservative into UN-certified drums and IBCs. Our packaging lines regularly undergo third-party testing to ensure leak-proof performance and impact resistance that meet or exceed international standards. Labels include hazard pictograms: dead tree and fish, exclamation mark, and product code, all directly traceable to the batch. Industrial closures prevent leaks during handling. Each container’s closure integrity and labeling accuracy are double-checked at final loading. We have built familiarity with the sort of scrutiny expected at ports from years of direct shipments.
We maintain dialogue with dangerous goods safety advisors and regularly update our logistics and management teams on new transport regulations. Our participation in chemicals industry associations allows us to anticipate changes to CIT/MIT classification and shipping rules before they come into force. This experience helps us avoid disruption and continue supplying critical biocidal ingredients to our clients worldwide. Our records show that correct adherence to hazardous goods transport requirements prevents accidents, regulatory fines, and delivery failures. That is why regulatory knowledge is not just a compliance burden, but a core part of reliable service.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales4@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
